Matthew McCoy

@matthew_s_mccoy

Assistant professor, Department of Medical Ethics and Health Policy, UPenn

Vrijeme pridruživanja: studeni 2012.
0 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @matthew_s_mccoy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @matthew_s_mccoy

  1. proslijedio/la je Tweet
    18. sij

    The real thing has arrived! We discuss a new framework for global health priority-setting that includes and goes beyond cost-effectiveness. With and many others.

    Korisnici , i
    10 replies 30 proslijeđenih tweetova 125 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    16. sij

    New viewpoint from , , and Zeke Emanuel: "The risk of exploitation needs to be addressed and strategies to prevent it devised."

    6 proslijeđenih tweetova 13 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    20. stu 2019.
    Odgovor korisniku/ci

    Agree. There are no "potential" conflicts of interests, period. and Zeke, writing in , are right.

    3 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  4. 13. stu 2019.

    If this is true, biases in public comments are less troubling, as committees will sort it all out in the end. If committees are swayed by enthusiastic comments that overwhelmingly favor expanding coverage, results are more concerning.

    1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  5. 13. stu 2019.

    Insightful commentary by on new study. A lot turns on notion that "Medicaid policy committees are skilled at aggregating information" and able to "judiciously weigh reporting from various interest groups as they apply rigorous standards of evidence"

    How bad is it that business interests are over-represented in public comments related to Medicaid coverage? In I have a few thoughts on public comments and industry interests as I noodle over Vinay's interesting analysis.
    1 reply 4 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  6. proslijedio/la je Tweet
    9. lis 2019.

    .One disclosure that might've included about this op-ed on is that receives significant financial support from . Top donors of $1m or more in 2018 include etc.

    1 reply 5 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    7. lis 2019.

    Interested in ethical, legal, & social implications (ELSI)of genomics (or know someone who is)? is accepting applications to our funded postdoctoral training program in ELSI research. Applications due December 10. Details here.

    27 proslijeđenih tweetova 15 korisnika označava da im se sviđa
    Poništi
  8. 2. lis 2019.

    weighed in as well.

    2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  9. 2. lis 2019.

    Last summer I wrote about the case for extending Sunshine Act reporting requirements to cover industry payments to patient orgs. At the time Sen. McCaskill had just proposed legislation to that effect. Interesting to see issue getting traction again.

    Here proposes changes to Open Payments re: industry payments to patient groups
    1 reply 6 proslijeđenih tweetova 5 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  10. 30. ruj 2019.

    Worth emphasizing, Collins got in trouble for insider trading. Had he stuck with *merely* being a board member and primary investor in a biotech company while crafting health care legislation on E&C Committee, he wouldn’t have broken any Congressional ethics rules.

    In light of Chris Collins' expected guilty plea for insider trading, just re-upping my and 's () op-ed on Collins and financial COIs among members of Congress in
    6 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    17. ruj 2019.

    . was recently featured in discussing how online purchasing for prescription drugs alters patient-physician relationships

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    25. srp 2019.

    Finally took the time to re-watch Ian Tannock's Allen Lichter Award Lecture. In particular, I wanted to accurately quote the following statement: "Disclosure of a conflict is not enough. We need to stop having these conflicts." 1/

    1 reply 5 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    15. srp 2019.

    New paper by , , and me looking at relationships between FDA advisory committee recommendations and eventual agency actions.

    7 proslijeđenih tweetova 22 korisnika označavaju da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    2. srp 2019.

    In which George Loewenstein and I assess what Open Payments has shown us and point out some unanticipated consequences of payments . It's important to not let sunshine half-measures prevent (or ) from taking more substantive actions

    Open Payments has largely confirmed what many critics of pharmaceutical and device firms have long argued: the reach of these industries in medicine is vast and their influence significant
    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  15. proslijedio/la je Tweet
    23. lip 2019.

    colleagues: Sign our letter laying out the ways in which the treatment of children being detained at the is a grave violation of the core principles of . Spread the word.

    1 reply 8 proslijeđenih tweetova 14 korisnika označava da im se sviđa
    Poništi
  16. 10. svi 2019.

    See the article on this issue from a few months back

    1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  17. 10. svi 2019.

    So it's possible for someone to look over a lot of the website and take the quiz referenced in the article without ever encountering the sponsorship information. This kind of non-transparent transparency is pretty common for disease awareness campaigns.

    1 reply 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  18. 10. svi 2019.

    Also worth noting how this is disclosed. The Right to Desire website does acknowledge that the campaign is funded by Sprout, but to see the information you've got to click on the FAQ page and scroll a little ways down.

    1 reply
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  19. 10. svi 2019.

    Perhaps everyone understands what's going on, but I think it's worth stating explicitly that the "Right to Desire" campaign is sponsored by Sprout Pharmaceuticals.

    Drug campaign touts 'female Viagra' in the name of equality:
    1 reply 1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    7. svi 2019.

    An essay in about industry payments, John Oliver , and the role of doctors in supporting transparency (disclosure: it's by me).

    Opinion: Physicians who refuse to take payments from drug or device companies should convey their payment-free status to current and prospective patients.
    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi

@matthew_s_mccoy još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·